Related Experiment Video
Updated: Nov 1, 2025

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Filamentous Bacteriophages and the Competitive Interaction between Pseudomonas aeruginosa Strains under Antibiotic
Julie D Pourtois1,2, Michael J Kratochvil3,4, Qingquan Chen4
1Department of Biology, Stanford University, Stanford, California, USA.
Abstract:
Pseudomonas aeruginosa (Pa) is a major bacterial pathogen responsible for chronic lung infections in cystic fibrosis patients. Recent work has implicated Pf bacteriophages, nonlytic filamentous viruses produced by Pa, in the chronicity and severity of Pa infections. Pf phages act as structural elements in Pa biofilms and sequester aerosolized antibiotics, thereby contributing to antibiotic tolerance. Consistent with a selective advantage in this setting, the prevalence of Pf-positive (Pf+) bacteria increases over time in these patients. However, the production of Pf phages comes at a metabolic cost to bacteria, such that Pf+ strains grow more slowly than Pf-negative (Pf-) strains in vitro. Here, we use a mathematical model to investigate how these competing pressures might influence the relative abundance of Pf+ versus Pf- strains in different settings. Our model suggests that Pf+ strains of Pa cannot outcompete Pf- strains if the benefits of phage production falls onto both Pf+ and Pf- strains for a majority of parameter combinations. Further, phage production leads to a net positive gain in fitness only at antibiotic concentrations slightly above the MIC (i.e., concentrations for which the benefits of antibiotic sequestration outweigh the metabolic cost of phage production) but which are not lethal for Pf+ strains. As a result, our model suggests that frequent administration of intermediate doses of antibiotics with low decay rates and high killing rates favors Pf+ over Pf- strains. These models inform our understanding of the ecology of Pf phages and suggest potential treatment strategies for Pf+ Pa infections. IMPORTANCE Filamentous phages are a frontier in bacterial pathogenesis, but the impact of these phages on bacterial fitness is unclear. In particular, Pf phages produced by Pa promote antibiotic tolerance but are metabolically expensive to produce, suggesting that competing pressures may influence the prevalence of Pf+ versus Pf- strains of Pa in different settings. Our results identify conditions likely to favor Pf+ strains and thus antibiotic tolerance. This study contributes to a better understanding of the unique ecology of filamentous phages in both environmental and clinical settings and may facilitate improved treatment strategies for combating antibiotic tolerance.
Insights
Pseudomonas aeruginosa strains producing Pf phages (Pf+) gain antibiotic tolerance but grow slower. Mathematical models show specific antibiotic dosing strategies can favor these tolerant Pf+ strains in infections.
Area of Science:
- Microbiology and Virology
- Bacterial Pathogenesis
- Mathematical Modeling in Biology
Background:
- Pseudomonas aeruginosa (Pa) causes chronic lung infections, particularly in cystic fibrosis patients.
- Pf bacteriophages, filamentous viruses produced by Pa, are linked to increased infection severity and antibiotic tolerance.
- Pf phage production incurs a metabolic cost, leading to slower growth of Pf-positive (Pf+) Pa strains compared to Pf-negative (Pf-) strains.
Purpose of the Study:
- To investigate the competing pressures of metabolic cost and antibiotic sequestration on the relative abundance of Pf+ and Pf- Pa strains.
- To determine conditions under which Pf+ strains can outcompete Pf- strains.
- To identify potential antibiotic treatment strategies that may target Pf+ Pa infections.
Main Methods:
- Development and analysis of a mathematical model simulating the population dynamics of Pf+ and Pf- Pa strains.
- Evaluation of fitness gains and losses based on phage production costs and antibiotic sequestration benefits.
- Exploration of various antibiotic administration parameters (dose, decay rate, killing rate) and their impact on strain prevalence.
Main Results:
- Pf+ strains generally do not outcompete Pf- strains unless benefits of phage production are restricted.
- Net fitness gain for Pf+ strains occurs only at antibiotic concentrations slightly above the minimum inhibitory concentration (MIC).
- Frequent administration of intermediate antibiotic doses with low decay and high killing rates favors the proliferation of Pf+ strains.
Conclusions:
- The ecological dynamics of Pf phages are influenced by a balance between metabolic costs and antibiotic sequestration benefits.
- Specific antibiotic treatment regimens, characterized by intermediate doses and high killing rates, can promote the selection of antibiotic-tolerant Pf+ Pa strains.
- Understanding these dynamics can inform the development of novel therapeutic strategies against chronic and antibiotic-tolerant Pa infections.

